KDM2BSynovial Cancer: KDM2B is required for proliferation independently of demethylase activity (>90% of these cancers). Pancreatic Cancer: KDM2B can activate genes involved in ribosomal and mitochondrial function. Here, KDM2B is linked to pancreatic neoplasm.